A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP

NCT04634604 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Lack of feasibility to recruit.

Conditions

Retinopathy of Prematurity

Interventions

DRUG: Bevacizumab
PROCEDURE: Laser

Sponsor

Jaeb Center for Health Research

Collaborators

[object Object]
[object Object]